Login

Maxime Séché is the Chief Executive Officer of Séché Environnement, a leading environmental services company. 00:10:00

Share On Facebook Share On Twitter

Joël Séché, Président Fondateur de Séché Environnement.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Market Insights and Operational Efficiency in Affordable Housing
00:10:00
Dr. Saloni Wagh Discusses Supriya Lifescience's Growth Strategy and Market Leadership | Saloni Wagh, Director, Supriya Lifescience Limited.
00:10:00
Canada Boosts Venture Capital with New Technology Investment Funds"
00:10:00
Rio Tinto Group’s underlying profit fell 12% last year on weaker commodities prices and rising costs, but the company still managed to pay a higher dividend|Jakob Stausholm,CEO,Rio Tinto Group
00:10:00
Daniel Needham on Aligning Investment Strategies with Client Goals
00:10:00
CEO Stefan Eriksson Breaks Down Tura Group’s Q1 2023 Report and Scandinavian Expansion | Stefan Eriksson, CEO, Tura Group AB.
00:10:00
Insights from Shemara's Three-Decade Journey at Macquarie Group |Shemara Wikramanayake , CEO, Macquarie Group.
00:10:00
PKH Ventures IPO Set to Launch on June 30 with Fresh Equity Issue and OFS | Pravin Kumar Agarwal , CMD, PKH Ventures Ltd.
00:10:00
Revitalizing Education Federalism: How Centralization and Local Empowerment Are Shaping 2030's Schools
00:10:00
Unveiling Blackham Resources: Driving Gold Production and Expansion in Western Australia
00:10:00
Privately owned hedge fund founded in 1999 investing across different sectors|Dan Rose,Chairman,Coatue
00:10:00
Bond supports visionary founders throughout their life cycle|Jay Simons,General Partner,Bond

© 2017 - Neuhu+